Key result
FLNC and TTN mutations mimic myocarditis in heart failure, highlighting the value of genetic testing.
Case Report (n=1)
No
In patients with newly diagnosed cardiomegaly and heart failure, even with evidence of myocarditis, genetic testing is crucial to identify hereditary forms of dilated cardiomyopathy that may progress despite optimal medical therapy.
Answers are grounded in this paper and cite their sources.
Supports considering genetic testing in myocarditis-like cardiomyopathy; leaves open routine use pending larger studies.
The article describes a clinical case of a combination of myocarditis and hereditary dilated cardiomyopathy. In a 40-year-old man cardiomegaly and HF, which occurred for the first time, were initially associated with an inflammatory process in the myocardium. Further genetic examinations showed that pathological processes in the myocardium are also associated with a pathogenic mutation in the FLNC gene and a mutation in the TNT gene. The myocarditis that developed on the background of family (hereditary) dilated cardiomyopathy. However, despite the positive effect of the treatment of myocarditis and contemporary drug therapy, the progression of the pathological process in the myocardium was noted. This clinical case emphasizes the importance of a complete diagnostic examination with the use of genetic testing in certain cases.
No takes yet. Share an insight, caveat, or question.
Onyshchenko et al. (2024) conducted a case report in Dilated cardiomyopathy and myocarditis (n=1). Heart failure therapy, immunosuppression, and ICD implantation was evaluated. A 40-year-old man with cardiomegaly and heart failure initially attributed to myocarditis was found to have pathogenic mutations in the FLNC and TTN genes, emphasizing the need for genetic testing.
Synapse has enriched 10 related papers. Consider them for comparative context: